These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 33688488)
1. PD-1, TIM-3, and LAG-3 Expression in T Cells in a Patient with Recurrent Ossifying Fibroma: A Case Report. García-Muñoz A; Nieto-Velázquez NG; Damian-Morales G; Liceaga-Escalera C; Montoya-Perez LA; Cruz-Vélez M; Gómez-Hernández PA; Trejo-Iriarte C; Pastelin-Palacios R; Moreno-Eutimio MA Int J Mol Cell Med; 2020; 9(4):307-312. PubMed ID: 33688488 [TBL] [Abstract][Full Text] [Related]
2. Extensive presentation of central ossifying fibroma treated with conservative surgical excision. Dominguete MH; Dominguette AA; Matos BH; Dominguete PR; León JE; Oliveira LR Case Rep Dent; 2014; 2014():204258. PubMed ID: 25506435 [TBL] [Abstract][Full Text] [Related]
3. PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors. Wang JJ; Burger P; Taube J; Soni A; Chaichana K; Sheu M; Belcaid Z; Jackson C; Lim M Cureus; 2019 Dec; 11(12):e6352. PubMed ID: 31938638 [TBL] [Abstract][Full Text] [Related]
4. Recurrent peripheral ossifying fibroma: Case report. Nadimpalli H; Kadakampally D Dent Med Probl; 2018; 55(1):83-86. PubMed ID: 30152640 [TBL] [Abstract][Full Text] [Related]
5. Ossifying fibroma. A case report. Taşar F; Giray CB; Taşman U; Saysel MY Turk J Pediatr; 1996; 38(2):265-70. PubMed ID: 8701497 [TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4 Saleh R; Toor SM; Khalaf S; Elkord E Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31614877 [No Abstract] [Full Text] [Related]
7. Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses. Chen X; Pan X; Zhang W; Guo H; Cheng S; He Q; Yang B; Ding L Acta Pharm Sin B; 2020 May; 10(5):723-733. PubMed ID: 32528824 [TBL] [Abstract][Full Text] [Related]
8. Increased exhausted CD8 Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497 [TBL] [Abstract][Full Text] [Related]
9. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines. Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448 [TBL] [Abstract][Full Text] [Related]
10. Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome. Araujo B de Lima V; Borch A; Hansen M; Draghi A; Spanggaard I; Rohrberg K; Reker Hadrup S; Lassen U; Svane IM Cytotherapy; 2020 Apr; 22(4):204-213. PubMed ID: 32201034 [TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4 Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E Front Immunol; 2019; 10():2936. PubMed ID: 31921188 [TBL] [Abstract][Full Text] [Related]
13. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. Qin S; Xu L; Yi M; Yu S; Wu K; Luo S Mol Cancer; 2019 Nov; 18(1):155. PubMed ID: 31690319 [TBL] [Abstract][Full Text] [Related]
14. TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas. Li Z; Liu X; Guo R; Wang P Tumour Biol; 2017 May; 39(5):1010428317698352. PubMed ID: 28475007 [TBL] [Abstract][Full Text] [Related]
15. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus. Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915 [TBL] [Abstract][Full Text] [Related]
16. Juvenile Ossifying Fibroma of Maxilla. Chaurasia NK; Koju S; Dulal S; Upadhyaya C Kathmandu Univ Med J (KUMJ); 2018 Jul-Sept.; 16(63):263-265. PubMed ID: 31719318 [TBL] [Abstract][Full Text] [Related]
18. Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules. D'Arrigo P; Tufano M; Rea A; Vigorito V; Novizio N; Russo S; Romano MF; Romano S Curr Med Chem; 2020; 27(15):2402-2448. PubMed ID: 30398102 [TBL] [Abstract][Full Text] [Related]
19. Tumor antigen-specific CD8 Lu X; Yang L; Yao D; Wu X; Li J; Liu X; Deng L; Huang C; Wang Y; Li D; Liu J Cell Immunol; 2017 Mar; 313():43-51. PubMed ID: 28110884 [TBL] [Abstract][Full Text] [Related]
20. Three types of ossifying fibroma: A report of 4 cases with an analysis of CBCT features. Jih MK; Kim JS Imaging Sci Dent; 2020 Mar; 50(1):65-71. PubMed ID: 32206622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]